A Quantitative Intersectionality Analysis of HIV/STI Prevention and Healthcare Access Among Transgender and Nonbinary People.
Journal
Epidemiology (Cambridge, Mass.)
ISSN: 1531-5487
Titre abrégé: Epidemiology
Pays: United States
ID NLM: 9009644
Informations de publication
Date de publication:
01 11 2023
01 11 2023
Historique:
pmc-release:
01
11
2024
medline:
29
9
2023
pubmed:
27
9
2023
entrez:
27
9
2023
Statut:
ppublish
Résumé
Transgender and nonbinary people experience substantial barriers to accessing healthcare, including prevention of HIV and other sexually transmitted infections (HIV/STI), due to structural inequities. We examined differences in insurance, HIV/STI prevalence, testing, and preexposure prophylaxis use among transgender and nonbinary people living in Washington State by race and ethnicity and gender. We pooled data from five 2019-2021 Washington State HIV/STI surveillance data sources to obtain a large and diverse sample of 1648 transgender and nonbinary participants. We calculated the risk difference (RD) for each outcome and used Poisson regression to estimate a surrogate measure of additive interaction-attributable proportion (AP)-that measures the proportion of the excess prevalence of the outcome observed at the intersection of gendered and racialized experience, beyond that expected from gender or race and ethnicity alone. Participants reported overall high levels of poverty (29% incomes <$15,000 and 7% unstable housing). Certain groups, especially racial/ethnic minority transgender women, were disproportionately impacted by HIV/STIs (RDs from 20% to 43% and APs from 50% to 85%) and less likely to currently have insurance (RDs from 25% to 39% and APs from 74% to 93%) than that expected based on gendered or racialized experience alone. Our findings highlight the heterogeneity in insurance access, HIV/STI positivity, and prevention utilization within transgender communities. We observed that a large proportion of increased HIV/STI prevalence among racial/ethnic minority transgender women was attributable to the intersection of gender and race and ethnicity. Our findings highlight the importance of trans-inclusive models of HIV/STI prevention that address multilevel barriers rooted in cissexism and structural racism.
Sections du résumé
BACKGROUND
Transgender and nonbinary people experience substantial barriers to accessing healthcare, including prevention of HIV and other sexually transmitted infections (HIV/STI), due to structural inequities. We examined differences in insurance, HIV/STI prevalence, testing, and preexposure prophylaxis use among transgender and nonbinary people living in Washington State by race and ethnicity and gender.
METHODS
We pooled data from five 2019-2021 Washington State HIV/STI surveillance data sources to obtain a large and diverse sample of 1648 transgender and nonbinary participants. We calculated the risk difference (RD) for each outcome and used Poisson regression to estimate a surrogate measure of additive interaction-attributable proportion (AP)-that measures the proportion of the excess prevalence of the outcome observed at the intersection of gendered and racialized experience, beyond that expected from gender or race and ethnicity alone.
RESULTS
Participants reported overall high levels of poverty (29% incomes <$15,000 and 7% unstable housing). Certain groups, especially racial/ethnic minority transgender women, were disproportionately impacted by HIV/STIs (RDs from 20% to 43% and APs from 50% to 85%) and less likely to currently have insurance (RDs from 25% to 39% and APs from 74% to 93%) than that expected based on gendered or racialized experience alone.
CONCLUSIONS
Our findings highlight the heterogeneity in insurance access, HIV/STI positivity, and prevention utilization within transgender communities. We observed that a large proportion of increased HIV/STI prevalence among racial/ethnic minority transgender women was attributable to the intersection of gender and race and ethnicity. Our findings highlight the importance of trans-inclusive models of HIV/STI prevention that address multilevel barriers rooted in cissexism and structural racism.
Identifiants
pubmed: 37756272
doi: 10.1097/EDE.0000000000001669
pii: 00001648-990000000-00182
pmc: PMC10539029
mid: NIHMS1927946
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
827-837Subventions
Organisme : NIAID NIH HHS
ID : F31 AI152542
Pays : United States
Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest.
Références
BMC Health Serv Res. 2022 Mar 21;22(1):369
pubmed: 35307008
J Int AIDS Soc. 2016 Oct 18;19(7(Suppl 6)):21105
pubmed: 27760683
AIDS Behav. 2021 Jul;25(7):2301-2315
pubmed: 33515132
Soc Psychiatry Psychiatr Epidemiol. 2016 Oct;51(10):1349-1359
pubmed: 27531592
J Gen Intern Med. 2019 Oct;34(10):2068-2074
pubmed: 31385209
AIDS. 2022 Feb 1;36(2):305-315
pubmed: 34690282
LGBT Health. 2021 Feb-Mar;8(2):116-124
pubmed: 33567245
Behav Med. 2019 Apr-Jun;45(2):143-152
pubmed: 31343968
Transgend Health. 2020 Jun 08;5(2):75-79
pubmed: 32656351
PLoS Med. 2020 May 28;17(5):e1003125
pubmed: 32463815
J Acquir Immune Defic Syndr. 2020 Aug 15;84(5):437-442
pubmed: 32692101
SSM Popul Health. 2020 May 28;11:100608
pubmed: 32529022
Epidemiology. 2022 May 1;33(3):395-405
pubmed: 35213512
Soc Sci Med. 2018 Apr;203:64-73
pubmed: 29199054
Epidemiology. 2014 Sep;25(5):711-22
pubmed: 25051310
Transgend Health. 2019 Oct 29;4(1):287-296
pubmed: 31663035
J Int AIDS Soc. 2020 Jun;23 Suppl 3:e25539
pubmed: 32602642
Am J Prev Med. 2020 Nov;59(5):639-647
pubmed: 32792281
Am J Public Health. 2021 Mar;111(3):446-456
pubmed: 33476238
Ann Fam Med. 2022 Mar-Apr;20(2):157-163
pubmed: 35045967
J Int AIDS Soc. 2019 Sep;22(9):e25391
pubmed: 31536171
Soc Sci Med. 2014 Jun;110:10-7
pubmed: 24704889
J Assoc Nurses AIDS Care. 2009 Sep-Oct;20(5):348-61
pubmed: 19732694
AIDS Behav. 2017 Sep;21(9):2774-2783
pubmed: 28035497
SSM Popul Health. 2021 Apr 16;14:100798
pubmed: 33997247
PLoS One. 2022 Jun 16;17(6):e0269776
pubmed: 35709158
Sex Transm Infect. 2014 Aug;90(5):430-3
pubmed: 24714446
Transgend Health. 2021 Oct 04;6(5):275-283
pubmed: 34993300
LGBT Health. 2018 Oct;5(7):387-390
pubmed: 30272493
Sex Roles. 2013 Jun 1;68(11-12):675-689
pubmed: 23729971
Med Care. 2016 Nov;54(11):1010-1016
pubmed: 27314263
J Acquir Immune Defic Syndr. 2021 Dec 15;88(S1):S27-S38
pubmed: 34757990
AIDS Behav. 2022 Nov;26(11):3713-3725
pubmed: 35661016
SSM Popul Health. 2021 Nov 20;16:100977
pubmed: 34869821
Int J Transgend Health. 2020 Jul 2;21(3):337-349
pubmed: 34993513
AIDS Care. 2018 Jan;30(1):9-17
pubmed: 28791876
Int J Transgend Health. 2021 Mar 23;23(1-2):133-148
pubmed: 35403114
Clin Infect Dis. 2023 Feb 8;76(3):e736-e743
pubmed: 35594554
Am J Public Health. 2018 Jan;108(1):128-130
pubmed: 29161069
Am J Prev Med. 2018 Sep;55(3):336-344
pubmed: 30031640
Am J Public Health. 2012 Jul;102(7):1267-73
pubmed: 22594719
AIDS Educ Prev. 2017 Aug;29(4):302-314
pubmed: 28825860
Soc Psychiatry Psychiatr Epidemiol. 2022 May;57(5):963-971
pubmed: 35137246
Am J Public Health. 2019 Jan;109(1):e1-e8
pubmed: 30496000
LGBT Health. 2022 Apr;9(3):161-168
pubmed: 35180360
Soc Sci Med. 2020 Jan;245:112499
pubmed: 31542315
Soc Sci Med. 2018 Apr;203:74-80
pubmed: 29305018